2025年多囊卵巢综合征:见解与创新
多囊卵巢综合征(PCOS)是育龄女性最常见的内分泌疾病,抗苗勒管激素水平成为反映卵巢储备并可能参与发病的独特生物标志物。PCOS被视为心血管疾病风险增强因素,与肠道菌群失调、代谢紊乱及抑郁焦虑相关;早期诊断和心血管代谢筛查有助于改善长期结局。
要点
- 抗苗勒管激素水平是反映卵巢储备并可能参与PCOS发病的独特生物标志物。
- PCOS被视为心血管疾病风险增强因素,与心肌梗死和卒中风险升高相关。
- PCOS肠道菌群改变可能参与代谢功能障碍和炎症,并与抑郁焦虑相关。
核心结论
- PCOS是育龄女性最常见的内分泌疾病,对生殖、代谢、心血管和心理健康有广泛影响。
- 将PCOS视为心血管疾病风险增强因素并早期诊断,有望改善患者长期结局和生活质量。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- PCOS女性一生中肥胖、代谢综合征和2型糖尿病风险升高,即使在育龄期心肌梗死和卒中风险也增加。
- PCOS中观察到的肠道菌群改变可能参与代谢功能障碍和炎症,为创新治疗策略提供方向。
- PCOS中抑郁和焦虑等心理健康障碍高发,可能与肠道菌群失调相关。
- 近期研究显示PCOS女性神经影像和认知功能与对照存在差异,但需严格评估其他影响因素和纵向变化。
关键数值与推荐
- 原文未报告具体标准与数值。
临床怎么用
- 鉴于多系统共病患病率增加,早期诊断(尤其青春期)有助于适当咨询、实施早期预防和频繁心血管代谢筛查。
- 这些进展最终将促进新型疗法开发,并实现全面、以患者为中心和循证的照护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with broad implications for reproductive, metabolic, cardiovascular, and psychological health. Antimüllerian hormone level has emerged as a unique biomarker reflecting both ovarian reserve and possibly playing a significant role as a neuroactive hormone in the pathogenesis of PCOS. Beyond reproductive concerns, PCOS confers an elevated lifetime risk of obesity, metabolic syndrome, and type 2 diabetes. With increasing evidence for the risk of myocardial infarction and stroke even in the reproductive years, PCOS is now considered a cardiovascular disease risk-enhancing factor. Novel insights into the alterations observed in the gut microbiome in PCOS suggest possible contributions to metabolic dysfunction and inflammation, opening avenues for innovative therapeutic strategies. Expanding on the gut-PCOS connection, the high prevalence of mental health disorders such as depression and anxiety observed in PCOS may be linked to gut dysbiosis. Although recent studies indicate differences in neuroimaging and cognitive function in women with PCOS compared with controls, rigorous evaluation accounting for other factors influencing cognition and longitudinal changes is needed. Given the increased prevalence of multisystem comorbidities, early diagnosis, especially in adolescence, will allow appropriate counseling and implementation of early prevention and frequent cardiometabolic screening. Together, these developments will ultimately allow for the development of novel therapies and result in comprehensive, patient-centered, and evidence-based care. Advances in understanding the pathogenesis of PCOS and its associated comorbidities and recognizing PCOS as a cardiovascular disorder risk-enhancing condition hold promise for improving long-term outcomes and quality of life for women living with PCOS.
引用
- Dokras A. Polycystic ovary syndrome in 2025-insights and innovations. Fertil Steril. 2025. PMID: 40992713. doi:10.1016/j.fertnstert.2025.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。